Complex genetic and epigenetic modifications underlie the initiation and progression of cancer. Scientists are attempting to unravel the epigenome to gain an understanding of the interplay between oncogenesis and epigenetics. To explore these issues, The Scientist has assembled a panel of experts to discuss the importance of epigenetic profiling in cancer research, and to explore how this knowledge can be applied to develop targeted therapies. Attendees will have the opportunity to interact with the experts, ask questions, and seek advice on topics related to their research.
Topics to be covered include:
Meet the Speakers:
Dr. Ahmad M. Khalil
Assistant Professor of Genetics and Genome Sciences
Kavli Fellow (2014-Present)
Case Western Reserve University School of Medicine
Dr. Lanlan Shen
Associate Professor
Baylor College of Medicine
Sponsored by
